These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3260986)

  • 1. Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates.
    Ghilardi MF; Chung E; Bodis-Wollner I; Dvorzniak M; Glover A; Onofrj M
    Life Sci; 1988; 43(3):255-62. PubMed ID: 3260986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model.
    Ghilardi MF; Bodis-Wollner I; Onofrj MC; Marx MS; Glover AA
    Brain; 1988 Feb; 111 ( Pt 1)():131-49. PubMed ID: 3259150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
    Falardeau P; Bouchard S; Bédard PJ; Boucher R; Di Paolo T
    Eur J Pharmacol; 1988 May; 150(1-2):59-66. PubMed ID: 3261249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different sensitivities to MPTP toxicity in primate nigrostriatal and retinal dopaminergic systems: electrophysiological and biochemical evidence.
    Harnois C; Marcotte G; Di Paolo T
    Exp Eye Res; 1989 Oct; 49(4):543-52. PubMed ID: 2806423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.
    Pérez-Otaño I; Oset C; Luquin MR; Herrero MT; Obeso JA; Del Río J
    Neurosci Lett; 1994 Jul; 175(1-2):121-5. PubMed ID: 7970192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl.
    Saitoh T
    J Neurol Sci; 1988 Feb; 83(2-3):161-6. PubMed ID: 3258627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The catecholamine uptake blocker nomifensine protects against MPTP-induced parkinsonism in monkeys.
    Schultz W; Scarnati E; Sundström E; Tsutsumi T; Jonsson G
    Exp Brain Res; 1986; 63(1):216-20. PubMed ID: 3488228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.
    Schneider JS; Pope A; Simpson K; Taggart J; Smith MG; DiStefano L
    Science; 1992 May; 256(5058):843-6. PubMed ID: 1350379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
    Jenner P; Rupniak NM; Rose S; Kelly E; Kilpatrick G; Lees A; Marsden CD
    Neurosci Lett; 1984 Sep; 50(1-3):85-90. PubMed ID: 6436758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.
    Zuddas A; Oberto G; Vaglini F; Fascetti F; Fornai F; Corsini GU
    J Neurochem; 1992 Aug; 59(2):733-9. PubMed ID: 1629743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral metabolism of parkinsonian primates 21 days after MPTP.
    Schwartzman RJ; Alexander GM; Ferraro TN; Grothusen JR; Stahl SM
    Exp Neurol; 1988 Dec; 102(3):307-13. PubMed ID: 3264247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The visual system in Parkinson's disease.
    Bodis-Wollner I; Tagliati M
    Adv Neurol; 1993; 60():390-4. PubMed ID: 8420159
    [No Abstract]   [Full Text] [Related]  

  • 13. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
    German DC; Dubach M; Askari S; Speciale SG; Bowden DM
    Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal cord metabolism of the 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkey.
    Schwartzman RJ; Alexander GM
    Brain Res; 1985 Jul; 337(2):263-8. PubMed ID: 3875382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys.
    Eidelberg E; Brooks BA; Morgan WW; Walden JG; Kokemoor RH
    Neuroscience; 1986 Aug; 18(4):817-22. PubMed ID: 3489906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
    Doudet DJ; Chan GL; Holden JE; McGeer EG; Aigner TA; Wyatt RJ; Ruth TJ
    Synapse; 1998 Jul; 29(3):225-32. PubMed ID: 9635892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.
    Guttman M; Yong VW; Kim SU; Calne DB; Martin WR; Adam MJ; Ruth TJ
    Synapse; 1988; 2(5):469-73. PubMed ID: 3263709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys.
    Wolters EC; Kebabian JC; Guttman M; Mak E; Pate BD; Calne DB
    Neurosci Lett; 1988 Dec; 95(1-3):257-61. PubMed ID: 3265771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
    Rose S; Nomoto M; Kelly E; Kilpatrick G; Jenner P; Marsden CD
    Neurosci Lett; 1989 Jul; 101(3):305-10. PubMed ID: 2505199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.
    Di Paolo T; Bédard P; Daigle M; Boucher R
    Brain Res; 1986 Aug; 379(2):286-93. PubMed ID: 2427166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.